Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1), 328–357 (2018).Article
PubMed
Google Scholar
Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15(1), 11–20 (2018).Article
PubMed
Google Scholar
Ekstedt, M. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61(5), 1547–1554 (2015).Article
CAS
PubMed
Google Scholar
Singh, S. et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and meta-analysis of paired-biopsy studies. Clin. Gastroenterol. Hepatol. 13(4), 643–654 (2015).Article
PubMed
Google Scholar
Cassidy, S. & Syed, B. A. Nonalcoholic steatohepatitis (NASH) drugs market. Nat. Rev. Drug Discov. 15(11), 745–746 (2016).Article
CAS
PubMed
Google Scholar
Wong, R. J. et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148(3), 547–555 (2015).Article
PubMed
Google Scholar
Beverly, J. K. & Budoff, M. J. Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. J. Diabetes 12(2), 102–104 (2020).Article
PubMed
Google Scholar
Virani, S. S. et al. Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation 141(9), e139–e596 (2020).Article
PubMed
Google Scholar
Bergström, G. et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation 144(12), 916–929 (2021).Article
PubMed
PubMed Central
Google Scholar
Kim, K., Ginsberg, H. N. & Choi, S. H. New, novel lipid-lowering agents for reducing cardiovascular risk: Beyond statins. Diabetes Metab. J. 46(4), 517–532 (2022).Article
PubMed
PubMed Central
Google Scholar
van den Hoek, A. M. et al. Unraveling the transcriptional dynamics of NASH pathogenesis affecting atherosclerosis. Int. J. Mol. Sci. 23(15), 8229 (2022).Article
PubMed
PubMed Central
Google Scholar
Gutiérrez-Cuevas, J., Santos, A. & Armendariz-Borunda, J. Pathophysiological molecular mechanisms of obesity: A link between MAFLD and NASH with cardiovascular diseases. Int. J. Mol. Sci. 22(21), 11629 (2021).Article
PubMed
PubMed Central
Google Scholar
Spahillari, A. et al. The association of lean and fat mass with all-cause mortality in older adults: The Cardiovascular Health Study. Nutr. Metab. Cardiovasc. Dis. 26(11), 1039–1047 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Wong, C. R. & Lim, J. K. The association between nonalcoholic fatty liver disease and cardiovascular disease outcomes. Clin. Liver Dis. (Hoboken) 12(2), 39–44 (2018).Article
PubMed
Google Scholar
Vanni, E., Marengo, A., Mezzabotta, L. & Bugianesi, E. Systemic complications of nonalcoholic fatty liver disease: When the liver is not an innocent bystander. Semin. Liver Dis. 35(3), 236–249 (2015).Article
PubMed
Google Scholar
Zhou, J. H., Cai, J. J., She, Z. G. & Li, H. L. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World J. Gastroenterol. 25(11), 1307–1326 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Steenman, M. et al. Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries. Sci. Rep. 8(1), 3940 (2018).Article
ADS
PubMed
PubMed Central
Google Scholar
Arendt, B. M. et al. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Hepatology 61(5), 1565–1578 (2015).Article
CAS
PubMed
Google Scholar
Langfelder, P. & Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).Article
Google Scholar
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015).Article
PubMed
PubMed Central
Google Scholar
Sherman, B. T. et al. DAVID: A web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50(W1), W216–W221 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587–D592 (2023).Article
CAS
PubMed
Google Scholar
Szklarczyk, D. et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 49(D1), D605–D612 (2021).Article
CAS
PubMed
Google Scholar
Chin, C. H. et al. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8(Suppl 4), S11 (2014).Article
PubMed
PubMed Central
Google Scholar
Ayari, H. & Bricca, G. Identification of two genes potentially associated in iron-heme homeostasis in human carotid plaque using microarray analysis. J. Biosci. 38(2), 311–315 (2013).Article
CAS
PubMed
Google Scholar
Ahrens, M. et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 18(2), 296–302 (2013).Article
CAS
PubMed
Google Scholar
Robin, X. et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).Article
Google Scholar
Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12(5), 453–457 (2015).Article
CAS
PubMed
PubMed Central
Google Scholar
Hu, K. Become competent within one day in generating boxplots and violin plots for a novice without prior R experience. Methods Protoc. 3(4), 64 (2020).Article
PubMed
PubMed Central
Google Scholar
Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102(43), 15545–15550 (2005).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Hänzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).Article
Google Scholar
Huang, H. Y. et al. miRTarBase update 2022: An informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 50(D1), D222–D230 (2022).Article
CAS
PubMed
Google Scholar
Huang, L., Zhang, L. & Chen, X. Updated review of advances in microRNAs and complex diseases: Experimental results, databases, webservers and data fusion. Brief. Bioinform. 23(6), bbac397 (2022).Article
PubMed
Google Scholar
Li, J. et al. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis. J. Ethnopharmacol. 322, 117600 (2023).Article
PubMed
Google Scholar
Tutunchi, H. et al. The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study. Int. J. Clin. Pract. 75(6), e14131 (2021).Article
CAS
PubMed
Google Scholar
Turecký, L., Kupčová, V., Urfinová, M., Repiský, M. & Uhlíková, E. Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease. Vnitr Lek. 67(E-2), 4–8 (2021).PubMed
Google Scholar
Nasiri-Ansari, N. et al. Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): A concise review. Cells 11(16), 2511 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Born, W. K., Reardon, C. L. & O’Brien, R. L. The function of gammadelta T cells in innate immunity. Curr. Opin. Immunol. 18(1), 31–38 (2006).Article
CAS
PubMed
Google Scholar
Bonneville, M., O’Brien, R. L. & Born, W. K. Gammadelta T cell effector functions: A blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10(7), 467–478 (2010).Article
CAS
PubMed
Google Scholar
Maniar, A. et al. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood 116(10), 1726–1733 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Cheng, H. Y., Wu, R. & Hedrick, C. C. Gammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis. Atherosclerosis 234(2), 265–269 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Kyaw, T. et al. Cytotoxic lymphocytes and atherosclerosis: Significance, mechanisms and therapeutic challenges. Br. J. Pharmacol. 174(22), 3956–3972 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Vu, D. M. et al. γδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice. PLoS One 9(10), e109416 (2014).Article
ADS
PubMed
PubMed Central
Google Scholar
Racanelli, V. & Rehermann, B. The liver as an immunological organ. Hepatology 43(2 Suppl 1), S54–S62 (2006).Article
CAS
PubMed
Google Scholar
Hammerich, L. et al. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology 59(2), 630–642 (2014).Article
CAS
PubMed
Google Scholar
Hammerich, L. & Tacke, F. Role of gamma-delta T cells in liver inflammation and fibrosis. World J. Gastrointest. Pathophysiol. 5(2), 107–113 (2014).Article
PubMed
PubMed Central
Google Scholar
Li, F. et al. The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner. Nat. Commun. 7, 13839 (2017).Article
ADS
PubMed
Google Scholar
Torres-Hernandez, A. et al. γδ T cells promote steatohepatitis by orchestrating innate and adaptive immune programming. Hepatology 71(2), 477–494 (2020).Article
CAS
PubMed
Google Scholar
Chen, Y. & Tian, Z. Roles of hepatic innate and innate-like lymphocytes in nonalcoholic steatohepatitis. Front. Immunol. 11, 1500 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, X. & Gao, B. γδT cells and CD1d, novel immune players in alcoholic and nonalcoholic steatohepatitis?. Hepatology 71(2), 408–410 (2020).Article
PubMed
Google Scholar
Bieghs, V., Rensen, P. C., Hofker, M. H. & Shiri-Sverdlov, R. NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages. Atherosclerosis 220(2), 287–293 (2012).Article
CAS
PubMed
Google Scholar
Wang, Y. et al. Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration. Br. J. Pharmacol. 171(3), 723–734 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang, H. et al. Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: A matched case-control study. Eur. J. Gastroenterol. Hepatol. 34(8), 838–843 (2022).Article
CAS
PubMed
Google Scholar
Kunutsor, S. K., Dey, R. S. & Laukkanen, J. A. Circulating serum copper is associated with atherosclerotic cardiovascular disease, but not venous thromboembolism: A prospective cohort study. Pulse (Basel) 9(3–4), 109–115 (2021).Article
PubMed
Google Scholar
Wang, D. et al. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomed. Pharmacother. 163, 114830 (2023).Article
CAS
PubMed
Google Scholar
Chen, C. et al. Copper exposure association with prevalence of non-alcoholic fatty liver disease and insulin resistance among US adults (NHANES 2011–2014). Ecotoxicol. Environ. Saf. 218, 112295 (2021).Article
CAS
PubMed
Google Scholar
Mazière, C., Conte, M. A. & Mazière, J. C. Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic. Biol. Med. 31(11), 1334–1340 (2001).Article
PubMed
Google Scholar
Huang, L., Zhang, L. & Chen, X. Updated review of advances in microRNAs and complex diseases: Taxonomy, trends and challenges of computational models. Brief. Bioinform. 23(5), bbac358 (2022).Article
PubMed
Google Scholar
Huang, L., Zhang, L. & Chen, X. Updated review of advances in microRNAs and complex diseases: Towards systematic evaluation of computational models. Brief. Bioinform. 23(6), bbac407 (2022).Article
PubMed
Google Scholar
Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R. & Honorio, K. M. Advances with support vector machines for novel drug discovery. Expert Opin. Drug Discov. 14(1), 23–33 (2019).Article
CAS
PubMed
Google Scholar
Yu, H. T. et al. Serum monokine induced by gamma interferon as a novel biomarker for coronary artery calcification in humans. Coron. Artery Dis. 26(4), 317–321 (2015).Article
PubMed
Google Scholar
Yu, H. T., Lee, J., Shin, E. C. & Park, S. Significant association between serum monokine induced by gamma interferon and carotid intima media thickness. J. Atheroscler. Thromb. 22(8), 816–822 (2015).Article
CAS
PubMed
Google Scholar
Liang, Y. et al. Serum monokine induced by gamma interferon is associated with severity of coronary artery disease. Int. Heart J. 58(1), 24–29 (2017).Article
CAS
PubMed
Google Scholar
Xie, J. H. et al. Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J. Leukoc. Biol. 73(6), 771–780 (2003).Article
CAS
PubMed
Google Scholar
Tsubaki, T. et al. Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin. Exp. Immunol. 141(2), 363–371 (2005).Article
CAS
PubMed
PubMed Central
Google Scholar
Ullah, A. et al. A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. Rev. Endocr. Metab. Disord. 24, 611–631 (2023).Article
CAS
PubMed
Google Scholar
Semba, T. et al. The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis. BMC Gastroenterol. 13, 120 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Li, L. et al. MIG/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg/Th17 balance. Exp. Cell Res. 407(2), 112801 (2021).Article
CAS
PubMed
Google Scholar
Zhu, M. et al. Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune ceRNA networks. BMC Complement. Altern. Med. 19(1), 156 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, W. et al. SPP1 and CXCL9 promote non-alcoholic steatohepatitis progression based on bioinformatics analysis and experimental studies. Front. Med. (Lausanne) 9, 862278 (2022).Article
PubMed
Google Scholar
Zhao, T. X., Newland, S. A. & Mallat, Z. 2019 ATVB plenary lecture: Interleukin-2 therapy in cardiovascular disease: The potential to regulate innate and adaptive immunity. Arterioscler. Thromb. Vasc. Biol. 40(4), 853–864 (2020).Article
CAS
PubMed
Google Scholar
Kuan, R., Agrawal, D. K. & Thankam, F. G. Treg cells in atherosclerosis. Mol. Biol. Rep. 48(5), 4897–4910 (2021).Article
CAS
PubMed
Google Scholar
Sharma, M. et al. Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression. Circ. Res. 127(3), 335–353 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Ou, H. X. et al. Regulatory T cells as a new therapeutic target for atherosclerosis. Acta Pharmacol. Sin. 39(8), 1249–1258 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang, C. Y., Liu, S. & Yang, M. Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy. World J. Gastroenterol. 28(27), 3346–3358 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Dywicki, J. et al. The detrimental role of regulatory T cells in nonalcoholic steatohepatitis. Hepatol. Commun. 6(2), 320–333 (2022).Article
CAS
PubMed
Google Scholar
Zhou, J., Zhang, Y. & Zhuang, Q. IL2RB affects Th1/Th2 and Th17 responses of peripheral blood mononuclear cells from septic patients. Allergol. Immunopathol. (Madr) 51(3), 1–7 (2023).Article
CAS
PubMed
Google Scholar
Yuan, X., Dong, Y., Tsurushita, N., Tso, J. Y. & Fu, W. CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms. JCI Insight 3(2), e96600 (2018).Article
PubMed
PubMed Central
Google Scholar
Mulholland, M. et al. IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice. Atherosclerosis 326, 1–10 (2021).Article
CAS
PubMed
Google Scholar
Xia, J. et al. Transcriptome analysis on the inflammatory cell infiltration of nonalcoholic steatohepatitis in bama minipigs induced by a long-term high-fat, high-sucrose diet. PLoS One 9(11), e113724 (2014).Article
ADS
PubMed
PubMed Central
Google Scholar
Wolak, T. Osteopontin—A multi-modal marker and mediator in atherosclerotic vascular disease. Atherosclerosis 236(2), 327–337 (2014).Article
CAS
PubMed
Google Scholar
O’Brien, E. R. et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14(10), 1648–1656 (1994).Article
CAS
PubMed
Google Scholar
Ohmori, R. et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 170(2), 333–337 (2003).Article
CAS
PubMed
Google Scholar
Momiyama, Y. et al. Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis. Atherosclerosis 210(2), 668–670 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Isoda, K. et al. Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 107(5), 679–681 (2003).Article
CAS
PubMed
Google Scholar
Zheng, Y. H. et al. Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J. Cell. Physiol. 227(1), 127–135 (2012).Article
CAS
PubMed
Google Scholar
Wang, G. et al. Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases. J. Genet. 95(3), 741–750 (2016).Article
CAS
PubMed
Google Scholar
Yilmaz, Y. et al. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease. Dig. Liver Dis. 45(1), 58–62 (2013).Article
CAS
PubMed
Google Scholar
Arendt, B. M. et al. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease. Nutrition 62, 100–107 (2019).Article
CAS
PubMed
Google Scholar
Herrera-Marcos, L. V. et al. Hepatic galectin-3 is associated with lipid droplet area in non-alcoholic steatohepatitis in a new swine model. Sci. Rep. 12(1), 1024 (2022).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Nardo, A. D. et al. Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma. Liver Int. 40(7), 1620–1633 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Tuomisto, T. T. et al. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovasc. Res. 78(1), 175–184 (2008).Article
CAS
PubMed
Google Scholar
Maneechotesuwan, K., Kasetsinsombat, K., Wongkajornsilp, A. & Barnes, P. J. Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism. Respir. Res. 17(1), 104 (2016).Article
PubMed
PubMed Central
Google Scholar
Kadoglou, N. P. et al. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. J. Vasc. Surg. 51(1), 114–121 (2010).Article
PubMed
Google Scholar
Goebel, J. et al. Atorvastatin affects interleukin-2 signaling by altering the lipid raft enrichment of the interleukin-2 receptor beta chain. J. Investig. Med. 53(6), 322–328 (2005).Article
CAS
PubMed
Google Scholar
Ferreira, G. A., Teixeira, A. L. & Sato, E. I. Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus. Lupus 19(8), 927–934 (2010).Article
CAS
PubMed
Google Scholar
Kaji, H. et al. Calcitonin inhibits osteopontin mRNA expression in isolated rabbit osteoclasts. Endocrinology 135(1), 484–487 (1994).Article
CAS
PubMed
Google Scholar
Khanna, A. Tacrolimus and cyclosporinein vitro and in vivo induce osteopontin mRNA and protein expression in renal tissues. Nephron Exp. Nephrol. 101(4), e119–e126 (2005).Article
CAS
PubMed
Google Scholar
Weng, Z. et al. All-trans retinoic acid promotes osteogenic differentiation and bone consolidation in a rat distraction osteogenesis model. Calcif. Tissue Int. 104(3), 320–330 (2019).Article
CAS
PubMed
Google Scholar
Peal, D. S., Burns, C. G., Macrae, C. A. & Milan, D. Chondroitin sulfate expression is required for cardiac atrioventricular canal formation. Dev. Dyn. 238(12), 3103–3110 (2009).Article
CAS
PubMed
PubMed Central
Google Scholar
Mergoni, G. et al. The effect of laser therapy on the expression of osteocalcin and osteopontin after tooth extraction in rats treated with zoledronate and dexamethasone. Support. Care Cancer 24(2), 807–813 (2016).Article
PubMed
Google Scholar
Katz, J. et al. Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. Int. J. Oral Maxillofac. Surg. 40(6), 605–611 (2011).Article
CAS
PubMed
Google Scholar
Robert, L., Brechemier, D., Godeau, G., Labat, M. L. & Milhaud, G. Prevention of experimental immunarteriosclerosis by calcitonin. Biochem. Pharmacol. 26(22), 2129–2135 (1977).Article
CAS
PubMed
Google Scholar
Nishizawa, Y. et al. Calcium/calmodulin-mediated action of calcitonin on lipid metabolism in rats. J. Clin. Investig. 82(4), 1165–1172 (1988).Article
CAS
PubMed
PubMed Central
Google Scholar
Jacob, M. P. et al. Prevention by calcitonin of the pathological modifications of the rabbit arterial wall induced by immunization with elastin peptides: Effect on vascular smooth muscle permeability to ions. Exp. Mol. Pathol. 46(3), 345–356 (1987).Article
CAS
PubMed
Google Scholar
Mathiesen, D. S., Lund, A., Vilsbøll, T., Knop, F. K. & Bagger, J. I. Amylin and calcitonin: Potential therapeutic strategies to reduce body weight and liver fat. Front. Endocrinol. (Lausanne) 11, 617400 (2020).Article
PubMed
Google Scholar
Li, X., Shang, X. & Sun, L. Tacrolimus reduces atherosclerotic plaque formation in ApoE(−/−) mice by inhibiting NLRP3 inflammatory corpuscles. Exp. Ther. Med. 19(2), 1393–1399 (2020).CAS
PubMed
Google Scholar
Hamada, N. et al. Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model. Atherosclerosis 208(1), 97–103 (2010).Article
CAS
PubMed
Google Scholar
Love, S., Mudasir, M. A., Bhardwaj, S. C., Singh, G. & Tasduq, S. A. Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis. Oncotarget 8(69), 113403–113417 (2017).Article
PubMed
PubMed Central
Google Scholar
Deng, Q. & Chen, J. Potential therapeutic effect of all-trans retinoic acid on atherosclerosis. Biomolecules 12(7), 869 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Liu, Y. et al. Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease. Am. J. Clin. Nutr. 102(1), 130–137 (2015).Article
CAS
PubMed
Google Scholar
Geng, C. et al. Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1. Sci. China Life Sci. 60(11), 1234–1241 (2017).Article
CAS
PubMed
Google Scholar
Morrison, L. M. Response of ischemic heart disease to chondroitin sulfate-A. J. Am. Geriatr. Soc. 17(10), 913–923 (1969).Article
CAS
PubMed
Google Scholar
Morrison, L. M. & Enrick, N. Coronary heart disease: Reduction of death rate by chondroitin sulfate A. Angiology 24(5), 269–287 (1973).Article
CAS
PubMed
Google Scholar
Nakazawa, K. & Murata, K. Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects. Z. Alternsforsch. 34(2), 153–159 (1979).CAS
PubMed
Google Scholar
Herrero-Beaumont, G. et al. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br. J. Pharmacol. 154(4), 843–851 (2008).Article
CAS
PubMed
PubMed Central
Google Scholar
Melgar-Lesmes, P. et al. Chondroitin sulphate attenuates atherosclerosis in ApoE knockout mice involving cellular regulation of the inflammatory response. Thromb. Haemost. 118(7), 1329–1339 (2018).Article
PubMed
PubMed Central
Google Scholar
Melgar-Lesmes, P. et al. Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity. Atherosclerosis 245, 82–87 (2016).Article
CAS
PubMed
Google Scholar
Chen, L. et al. Chondroitin sulfate stimulates the secretion of H(2)S by Desulfovibrio to improve insulin sensitivity in NAFLD mice. Int. J. Biol. Macromol. 213, 631–638 (2022).Article
CAS
PubMed
Google Scholar
Gozzetti, A. et al. The effects of zoledronic acid on serum lipids in multiple myeloma patients. Calcif. Tissue Int. 82(4), 258–262 (2008).Article
CAS
PubMed
Google Scholar
Billington, E. O. & Reid, I. R. Benefits of bisphosphonate therapy: Beyond the skeleton. Curr. Osteoporos. Rep. 18(5), 587–596 (2020).Article
PubMed
Google Scholar
Wu, L. et al. Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells. Eur. J. Pharmacol. 602(1), 124–131 (2009).Article
CAS
PubMed
Google Scholar
Lo Presti, E., D’Orsi, L. & De Gaetano, A. A mathematical model of in vitro cellular uptake of zoledronic acid and isopentenyl pyrophosphate accumulation. Pharmaceutics 14(6), 1262 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Mohamed, R. H., Tarek, M., Hamam, G. G. & Ezzat, S. F. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; The potential role of mevalonic acid pathway in nonalcoholic steatohepatitis. Eur. J. Pharmacol. 858, 172469 (2019).Article
CAS
PubMed
Google Scholar
Toba, H., Cortez, D., Lindsey, M. L. & Chilton, R. J. Applications of miRNA technology for atherosclerosis. Curr. Atheroscler. Rep. 16(2), 386 (2014).Article
PubMed
PubMed Central
Google Scholar
Hochreuter, M. Y., Dall, M., Treebak, J. T. & Barrès, R. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives. Mol. Metab. 65, 101581 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Fang, M. et al. miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1. Cell Cycle 18(6–7), 682–695 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Tan, W. et al. The elevation of miR-185-5p alleviates high-fat diet-induced atherosclerosis and lipid accumulation in vivo and in vitro via SREBP2 activation. Aging (Albany NY) 14(4), 1729–1742 (2022).Article
CAS
PubMed
Google Scholar
Yang, M. et al. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake. J. Lipid Res. 55(2), 226–238 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Xi, X., Zheng, X., Zhang, R. & Zeng, L. Upregulation of circFOXP1 attenuates inflammation and apoptosis induced by ox-LDL in human umbilical vein endothelial cells by regulating the miR-185-5p/BCL-2 axis. Can. J. Physiol. Pharmacol. 100(11), 1045–1054 (2022).Article
CAS
Google Scholar
Wang, X. C., Zhan, X. R., Li, X. Y., Yu, J. J. & Liu, X. M. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease. World J. Gastroenterol. 20(47), 17914–17923 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Sun, D., Ma, T., Zhang, Y., Zhang, F. & Cui, B. Overexpressed miR-335-5p reduces atherosclerotic vulnerable plaque formation in acute coronary syndrome. J. Clin. Lab. Anal. 35(2), e23608 (2021).Article
CAS
PubMed
Google Scholar
Liu, Y. et al. H2O2 down-regulates SIRT7’s protective role of endothelial premature dysfunction via microRNA-335-5p. Biosci. Rep. 42(5), BSR20211775 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Ma, R. et al. miR-335-5p regulates the proliferation, migration and phenotypic switching of vascular smooth muscle cells in aortic dissection by directly regulating SP1. Acta Biochim. Biophys. Sin. (Shanghai) 54(7), 961–973 (2022).Article
CAS
PubMed
Google Scholar
Vienberg, S., Geiger, J., Madsen, S. & Dalgaard, L. T. MicroRNAs in metabolism. Acta Physiol. (Oxf.) 219(2), 346–361 (2017).Article
CAS
PubMed
Google Scholar
Zhang, J. W. & Pan, H. T. microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver. Genes Genomics 44(7), 879–888 (2022).Article
CAS
PubMed
Google Scholar
Zhang, Y. et al. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing. Ann. Hepatol. 19(3), 302–312 (2020).Article
CAS
PubMed
Google Scholar